Self-Motivation
David Goggins
Former Navy Seal
Career Development
Bryan Cranston
Actor
Critical Thinking
Liv Boeree
International Poker Champion
Emotional Intelligence
Amaryllis Fox
Former CIA Clandestine Operative
Management
Chris Hadfield
Retired Canadian Astronaut & Author
Learn
from the world's big
thinkers
Start Learning

Exploring the Future Frontiers of Human Health, with Francois Nader

The President & CEO of NPS Pharmaceuticals predicts tremendous growth for the pharmaceutical industry in the coming years as new cures and treatments are developed.

Francois Nader: I think we have tremendous, tremendous growth, tremendous potential in exploring the frontier of human beings. We are just at the very, very beginning of a very exciting adventure. And think of diseases as common cold, right. There is nothing terribly unusual about common cold, right. Yet we don’t have a cure for common cold yet, okay. Which is kind of ironic, right. Which means that innovation could be very small for small things like common cold or big things like Alzheimer’s and diabetes. We have multiple products for the diabetes today. We don’t have a cure for diabetes yet. Actually if you add Alzheimer’s and diabetes it could bankrupt our healthcare system. Yet we don’t have a cure for diabetes and we don’t know how to deal with Alzheimer’s yet. So if I look at the future a couple of things will happen.

One, we have phenomenal tools that will enable us to diagnose and to be more specific in better understanding the mechanism of virtually any disease. And the second aspect would be based on that we can start now, charter the road to better understanding the brain which will be a huge advancement.

We don’t know much about the brain. We know a few things here and there. But the brain is a huge unknown scientifically still. We don’t have a lot of tools yet to better understand how we think, the memory and everything related to our behavior. So the brain will be probably the next frontier.

But we should not forget that we have still about 6,000 rare diseases that do not have a treatment so we have a lot of work to do. And we cannot do it alone. I mean money and investment is one thing but we need to continue working on the framework of the regulatory agencies and how we can partner with the regulators to have a clearer path forward to having the new drugs approved.

The biggest challenge we face is science is moving so fast that the regulators have to catch up. They have to catch up to understand and catch up even more to regulate us which is a very daunting challenge and I really believe that the regulators are doing the right things in most of the cases. But at the same time I can only see the challenges that they have to better understand how the science is progressing. And you hear every day about the genomes and our understanding of the genomes. I mean this is absolutely flabbergasting the progress we’ve made over the last 15 years in better understanding the inner mechanics of how we work. And from there will come new medications, will come new cures, new treatments.

 

The President & CEO of NPS Pharmaceuticals predicts tremendous growth for the pharmaceutical industry in the coming years as new cures and treatments are developed. He also speaks about the broad scope of pharmaceutical research. The coming decades will see advances in treating minor issues such as the common cold, as well as broad steps forward in the fight against the frightening destruction of Alzheimer's disease.


The biggest challenge moving forward, says Nader, is for regulators to keep up with the radical growth and achievements sure to come. Policy and science need to remain on the same page in order to maximize the positive effects of research.

Live tomorrow! Unfiltered lessons of a female entrepreneur

Join Pulitzer Prize-winning reporter and best-selling author Charles Duhigg as he interviews Victoria Montgomery Brown, co-founder and CEO of Big Think, live at 1pm EDT tomorrow.

Improving Olympic performance with asthma drugs?

A study looks at the performance benefits delivered by asthma drugs when they're taken by athletes who don't have asthma.

Image source: sumroeng chinnapan/Shutterstock
Culture & Religion
  • One on hand, the most common health condition among Olympic athletes is asthma. On the other, asthmatic athletes regularly outperform their non-asthmatic counterparts.
  • A new study assesses the performance-enhancement effects of asthma medication for non-asthmatics.
  • The analysis looks at the effects of both allowed and banned asthma medications.

Keep reading Show less

Weird science shows unseemly way beetles escape after being eaten

Certain water beetles can escape from frogs after being consumed.

Surprising Science
  • A Japanese scientist shows that some beetles can wiggle out of frog's butts after being eaten whole.
  • The research suggests the beetle can get out in as little as 7 minutes.
  • Most of the beetles swallowed in the experiment survived with no complications after being excreted.
Keep reading Show less

Two MIT students just solved Richard Feynman’s famed physics puzzle

Richard Feynman once asked a silly question. Two MIT students just answered it.

Surprising Science

Here's a fun experiment to try. Go to your pantry and see if you have a box of spaghetti. If you do, take out a noodle. Grab both ends of it and bend it until it breaks in half. How many pieces did it break into? If you got two large pieces and at least one small piece you're not alone.

Keep reading Show less

Why are we fascinated by true crime stories?

Several experts have weighed in on our sometimes morbid curiosity and fascination with true crime.

Photo by Victoria Heath on Unsplash
Mind & Brain
  • True crime podcasts can get as many as 500,000 downloads per month. In the Top 100 Podcasts of 2020 list for Apple, several true crime podcasts ranked within the Top 20.
  • Our fascination with true crime isn't just limited to podcasts, with Netflix documentaries like "Confessions of a Killer: The Ted Bundy Tapes" scoring high popularity with viewers.
  • Several experts weigh in on our fascination with these stories with theories including fear-based adrenaline rushes and the inherent need to understand the human mind.
Keep reading Show less
Quantcast